Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rite Aid To Gain Specialty Drug, Part D Platforms With PBM EnvisionRx

This article was originally published in The Pink Sheet Daily

Executive Summary

The drug store chain will purchase EnvisionRx, which serves over 21 million members and expects to manage 145 million pharmacy claims in 2015, for $2 billion in cash and stock.

Advertisement

Related Content

Deal Watch: Teva Boosts CNS Portfolio With $3.2 Billion Purchase Of Auspex
OptumRx To Be ‘Competitive Force’ In PBM Industry With Catamaran Buy
Express Scripts-Medco Merger Closes With No Divestitures Needed
Medco Creates Largest U.S. Specialty Pharmacy Through Accredo Acquisition
Advance PCS To Step Up Mail Order, "Re-Contract" For Higher Rebates

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS078147

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel